Zhang, Xiaoming

Objective: The objective of this study is to predict in vivo lung mass density for patients with interstitial lung disease using different gradient boosting decision tree (GBDT) algorithms based on measurements from lung ultrasound surface wave elastography (LUSWE) and pulmonary function testing (PFT). Methods: Age and weight of study subjects (57 patients with interstitial lung disease and 20 healthy subjects), surface wave speeds at three vibration frequencies (100, 150, and 200 Hz) from LUSWE, and predicted forced expiratory volume (FEV1% pre) and ratio of forced expiratory volume to forced vital capacity (FEV1%/FVC%) from PFT were used as inputs while lung mass densities based on the Hounsfield Unit from high resolution computed tomography (HRCT) were used as labels to train the regressor in three GBDT algorithms, XGBoost, CatBoost, and LightGBM. 80% (20%) of the dataset was used for training (testing). Results: The results showed that predictions using XGBoost regressor obtained an accuracy of 0.98 in the test dataset. Conclusion: The obtained results suggest that XGBoost regressor based on the measurements from LUSWE and PFT may be able to noninvasively assess lung mass density in vivo for patients with pulmonary disease.

Ultrasonography is not widely used for lung assessment because ultrasound cannot image deep lung tissue. Many lung diseases including interstitial lung disease (ILD) are associated with changes in lung's elastic properties. ILD includes multiple serious lung disorders associated with lung fibrosis and can lead to respiratory failure and pulmonary hypertension. High-resolution CT (HRCT) is the clinical standard for diagnosing lung fibrosis, but it results in increased radiation exposure for patients. Lung fibrosis is associated with stiffened lung parenchyma. Current clinical techniques including HRCT cannot measure lung elastic properties. Most ILDs are typically distributed in the lung's peripheral and subpleural regions. We developed noninvasive lung ultrasound surface wave elastography (LUSWE) to measure lung surface wave speed safely and quickly. In this abstract, we will present some basics for LUSWE. We will also present its clinic application for assessing ILD. We studied 30 healthy controls, 16 mild ILD patients, 45 moderate ILD patients, and 27 severe ILD patients. Lung surface wave speed has good sensitivity and specificity for separating ILD patients from healthy subjects as well as for separating mild ILD patients from healthy subjects. LUSWE is useful for other lung disorders such as pulmonary edema.

Zebrafish are being increasingly used as animal models for human diseases such as cardiomyopathy and neuroblastoma because zebrafish have a nearly fully sequenced genome to humans. One pilot study is to develop zebrafish echocardiography. Because the heart of a zebrafish is small, a high frequency ultrasound system (50–80 MHz) is used for imaging. B-Mode imaging is analyzed for quantification of ejection fraction (EF), end-systolic volume (ESV), and end-diastolic volume (EDV). Pulse-wave Doppler (PWD) is used to calculate the E/A ratio (the peak velocities of E and A waves) and myocardial performance index (MPI). Techniques for improving image quality and repeatability of zebrafish echocardiography are discussed. Another pilot study is to develop zebrafish ultrasound vibro-elastography (ZUVE) for measuring the elastic properties of zebrafish. An adult female zebrafish is anesthetized for 3 min. A 0.1-s gentle harmonic vibration is generated on the tail of a zebrafish using a sphere tip indenter with a 3 mm diameter. Shear wave propagation in the zebrafish is measured using a high frequency 18 MHz ultrasound linear array probe. We conclude that ZUVE is safe, fast, and noninvasive and feasible for testing the elastic properties of zebrafish.

ObjectivesThe aim of this study was to assess bleomycin‐induced pulmonary fibrosis on ex vivo mouse lungs using ultrasound image grading and texture analysis.MethodsExcised mouse lungs were divided into 3 groups: control, mild fibrosis, and severe fibrosis based on the monitored indicators of health. B‐mode ultrasound images were obtained via scanning the mouse lungs ex vivo. The surface smoothness, echo density, and angle of lesions or the lung margin were graded, and the imaging contrast, correlation, homogeneity, and entropy were assessed via texture analysis.ResultsThe grades of surface smoothness, echo density, and angle were statistically higher for the severe fibrosis group compared with those of the control and mild fibrosis groups (P < .05). In addition, statistically significant differences in the contrast, correlation, and homogeneity between mild and severe fibrosis groups were observed (P < .05).ConclusionsThe results obtained in this study suggest that ultrasound image grading and texture analysis are valuable and meaningful methods for assessing pulmonary fibrosis in a bleomycin mouse model.

Background Lymphedema treatment is an ongoing challenge. It impacts quality of life due to pain, loss of range of motion of the extremity, and repeated episodes of cellulitis. Different modalities have been used to evaluate lymphedema; some are more error-prone and some are more invasive. However, these measurements are poorly standardized, and intrarater and interrater reliabilities are difficult to achieve. This pilot study aims to assess the feasibility of ultrasound vibroelastography for assessing patients with extremity lymphedema via measuring shear wave speeds of subcutaneous tissues. Methods Patients with clinical and lymphoscintigraphic diagnosis of secondary lymphedema in the extremities without prior surgical treatment were included. A 0.1-s harmonic vibration was generated at three frequencies (100, 150, and 200 Hz) by the indenter of a handheld shaker on the skin. An ultrasound probe was used for noninvasively capturing of wave propagation in the subcutaneous tissue. Wave speeds were measured in the subcutaneous tissues of both the control and affected extremities. Results A total of 11 female patients with secondary lymphedema in the extremities were enrolled in this study. The magnitudes of the wave speeds of the region of interest in the subcutaneous tissue at lymphedema sites in the upper extremity (3.9 ± 0.17 m/s, 5.96 ± 0.67 m/s, and 7.41 ± 1.09 m/s) were statistically higher than those of the control sites (2.1 ± 0.27 m/s, 2.93 ± 0.57 m/s, and 3.56 ± 0.76 m/s) at 100, 150, and 200 Hz (P < 0.05), and at 100 and 200 Hz (P < 0.05) between lymphedema (4.33 ± 0.35 m/s, 4.17 ± 1.00 m/s, and 4.56 ± 0.37 m/s) and controls sites (2.48 ± 0.43 m/s, 2.77 ± 0.55 m/s, and 3.06 ± 0.29 m/s) in the lower extremity. Conclusions These preliminary data suggest that ultrasound vibroelastography may be useful in the evaluation of secondary lymphedema and can be a valuable tool to noninvasively track treatment progress.

Lung edema is a common symptom of congestive heart failure and inflammatory conditions, such as acute respiratory distress syndrome. Currently, computed tomography (CT) is considered the standard to assess lung edema, but it requires ionizing radiation and poses a significant logistic burden. Lung ultrasound (LUS) has previously been used to assess lung edema using ultrasound B-line artifacts, but analysis of the B-line artifacts relies on visual interpretation. We developed lung ultrasound surface wave elastography (LUSWE) to measure lung surface wave speed safely. This project aims to evaluate LUSWE to quantify lung surface wave speed in an ex vivo water-filled swine lung. The lung surface wave speeds were measured at baseline and at frequencies of 100 Hz, 200 Hz, 300 Hz, and 400 Hz. Then, an amount of water was filled into the lung through its trachea. Ultrasound imaging was used to guide the water filling until significant changes were visible on the imaging. The lung surface wave speeds were measured. An additional 120 ml of water was then filled into the lung. The lung surface wave speeds were measured again. The results demonstrated that the lung surface wave speed decreased with respect to water content.

Extravascular lung water (EVLW) is a basic symptom of congestive heart failure and other conditions. Computed tomography (CT) is standard method used to assess EVLW, but it requires ionizing radiation and radiology facilities. Lung ultrasound reverberation artifacts called B-lines have been used to assess EVLW. However, analysis of B-line artifacts depends on expert interpretation and is subjective. Lung ultrasound surface wave elastography (LUSWE) was developed to measure lung surface wave speed. This pilot study aimed at measureing lung surface wave speed due to lung water in an ex vivo swine lung model. The surface wave speeds of a fresh ex vivo swine lung were measured at 100 Hz, 200 Hz, 300 Hz, and 400 Hz. An amount of water was then filled into the lung through its trachea. Ultrasound imaging was used to guide the water filling until significant changes were visible on the imaging. The lung surface wave speeds were measured again. It was found that the lung surface wave speed increases with frequency and decreases with water volume. These findings are confirmed by experimental results on an additional ex vivo swine lung sample.

Papilledema is optic nerve swelling caused by increased intracranial pressure, which has the potential to cause significant vision loss. Papilledema is typically bilateral and symmetric but can sometimes be asymmetric and even unilateral. The cause for this asymmetry is unknown. The purpose of this study was to utilize ultrasound vibro-elastography (UVE) to assess for biomechanical differences in eyes with papilledema. Nine patients with papilledema and 9 age-matched controls were enrolled. An external harmonic vibration was used to generate wave propagation through the eyelid with three excitation frequencies of 100, 150, and 200 Hz. A 6.4 MHz ultrasound probe was used to noninvasively measure the wave propagation in the posterior sclera to provide shear wave speeds and viscoelasticity (fit with Voigt model). The magnitudes of the shear wave speed and viscoelasticity of the idiopathic intracranial hypertension patients’ posterior sclera were significantly higher than those of healthy subjects. Moreover, for patients with unilateral papilledema, the magnitudes of wave speed and viscoelasticity of the posterior sclera were statistically higher in eyes with papilledema than in the contralateral eyes without papilledema. UVE provides a noninvasive technique to measure the viscoelastic properties of the posterior sclera, which is stiffer in eyes with papilledema.

Many lung diseases including interstitial lung disease (ILD) are associated with changes in the lung’s biomechanical properties. ILD comprises a number of serious diseases in which fibrosis stiffens and damages lung tissue. Most ILDs are typically distributed in the lung’s peripheral and subpleural regions. Pulmonary function test (PFT) and high-resolution computed tomography (HRCT) are used to assess ILD. Ultrasonography is not widely used for lung assessment because ultrasound cannot image deep lung tissue. We have developed lung ultrasound surface wave elastography (LUSWE) for measuring superficial lung wave speed. In LUSWE, a 0.1-s harmonic vibration is generated on the chest wall of a subject using a handheld vibrator. An ultrasound probe is aligned with the vibration excitation in the same intercostal space to measure the generated surface wave propagation on the lung. A human subject is examined in a sitting position. The lung is tested at the total lung volume and through six intercostal spaces. Significant differences of surface wave speed between patients and controls were found in 6 lung regions and for 3 excitation frequencies. A positive correlation between LUSWE and clinical tests including HRCT and PTF was found. LUSWE may complement the clinical standard HRCT for assessing ILD.

Lung ultrasound (LUS) detects the presence of extravascular lung water (EVLW) through the visualization of B-Line artifacts. However, the qualitative nature of LUS limits its effectiveness in serial or longitudinal studies such as evaluating changes in EVLW at different time points in patients undergoing diuretic therapy for congestive heart failure. Lung ultrasound surface wave elastography (LUSWE) is a novel technique using a small handheld device that can measure superficial lung tissue elastic properties. We aimed to evaluate the use of LUSWE to measure quantitative changes in lung elasticity caused by acute changes in EVLW. We performed LUSWE on consecutive days in 14 patients hospitalized for acute congestive heart failure with evidence of pulmonary edema (clinical EVLW). From day#1 to day#2, the patients had an average diuresis of net negative 2.1 l associated with an average decrease in 13 B-Lines by lung ultrasound, signifying a reduction in EVLW. LUSWE analysis demonstrated a significant reduction (p &lt; 0.05) in surface wave velocity in all interrogated intercostal spaces from day#1 to day#2. In summary, LUSWE performed at the bedside was able to demonstrate improvement in lung compliance (decreased elasticity) correlating with a reduction in EVLW in hospitalized patients being treated for congestive heart failure.